Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and SARS-CoV-2-Related Hospitalizations: A Statewide Report From the Minnesota Electronic Health Record Consortium

Using vaccine data combined with electronic health records, we report that mRNA boosters provide greater protection than a 2-dose regimen against SARS-CoV-2 infection and related hospitalizations. The benefit of a booster was more evident in the elderly and those with comorbidities.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2022-09, Vol.75 (5), p.890-892
Hauptverfasser:	Drawz, Paul E, DeSilva, Malini, Bodurtha, Peter, Vazquez Benitez, Gabriela, Murray, Anne, Chamberlain, Alanna M, Dudley, R Adams, Waring, Stephen, Kharbanda, Anupam B, Murphy, Daniel, Muscoplat, Miriam Halstead, Melendez, Victor, Margolis, Karen L, McFarling, Lynn, Lupu, Roxana, Winkelman, Tyler N A, Johnson, Steven G
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Aged BNT162 Vaccine COVID-19 - prevention & control Electronic Health Records Hospitalization Humans Minnesota - epidemiology RNA, Messenger SARS-CoV-2 - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Using vaccine data combined with electronic health records, we report that mRNA boosters provide greater protection than a 2-dose regimen against SARS-CoV-2 infection and related hospitalizations. The benefit of a booster was more evident in the elderly and those with comorbidities.
ISSN:	1058-4838 1537-6591
DOI:	10.1093/cid/ciac110